Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Spatial overlaps in the distribution of HIV/AIDS and malaria in Zimbabwe

Authors: Isaiah Gwitira, Amon Murwira, Joseph Mberikunashe, Mhosisi Masocha

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

In most developing economies particularly in Africa, more people are likely to die of HIV/AIDS and malaria compared to other diseases. HIV/AIDS tends to be superimposed on the long standing malaria burden particularly in sub-Saharan Africa. The detection and understanding of spatial overlaps in disease occurrence is important for integrated and targeted disease control. Integrated disease control can enhance efficiency and cost-effectiveness through the development of drugs targeting multiple infections in the same geographic space.

Methods

Using Zimbabwe as a case study, this study tests the hypothesis that malaria clusters coincide with HIV/AIDS clusters in space. Case data for the two diseases were obtained from the Ministry of Health and Child Care in Zimbabwe at district level via the District Health Information System (DHIS). Kulldorff’s spatial scan statistic was used to test for spatial overlaps in clusters of high cases of HIV/AIDS and malaria at district level. The spatial scan test was used to identify areas with higher cases of HIV/AIDS and malaria than would be expected under spatial randomness.

Results

Results of this study indicate that primary clusters of HIV/AIDS and malaria were not spatially coincident in Zimbabwe. While no spatial overlaps were detected between primary clusters of the two diseases, spatial overlaps were detected among statistically significant secondary clusters of HIV/AIDS and malaria. Spatial overlaps between HIV/AIDS and malaria occurred in five districts in the northern and eastern regions of Zimbabwe. In addition, findings of this study indicate that HIV/AIDS is more widespread in Zimbabwe compared to malaria.

Conclusions

The results of this study may therefore be used as a basis for spatially-targeted control of HIV/AIDS and malaria particularly in high disease burden areas. This is important as previous interventions have targeted the two diseases separately. Thus, targeted control could assist in resource allocation through prioritising areas in greatest need hence maximising the impact of disease control.
Literature
1.
2.
Kharsany ABM, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS Journal. 2016;10:34–48.CrossRef
3.
Dewald JR, Fuller DO, Müller GC, Beier JC. A novel method for mapping village-scale outdoor resting microhabitats of the primary African malaria vector, Anopheles gambiae. Malar J. 2016;15(489):1–12.
4.
World Health Organization (WHO). World Malaria Report 2017. Geneva: WHO; 2017.CrossRef
5.
Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science. 2006;314:1603–5.CrossRef
6.
UNICEF. Strategic framework for the Prev Control of HIV/AIDS and STI’s Within Somali Population. Nairobi: English Press Limited; 2003.
7.
Kwenti TE. Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies. Research and Reports in Tropical Medicine. 2018;9:123–36.CrossRef
8.
9.
Franke MF, Spiegelman D, Ezeamama A. Malaria parasitaemia and CD4 T cell count, viral load and adverse HIV outcomes among HIV-infected pregnant women in Tanzania. Am J Trop Med Hyg. 2010;82(4):556–62.CrossRef
10.
Nyabadza F, Bekele BT, Rúa MA, Malonza DM, Chiduku N, Kgosimore M. The implications of HIV treatment on the HIV-malaria coinfection dynamics: a modeling perspective. Biomed Res Int. 2015;2015:659651.CrossRef
11.
David AM, Mercado SP, Becker D, Edmundo K, Mugisha F. The prevention and control of HIV/AIDS, TB and vector-borne diseases in informal settlements: challenges, opportunities and insights. J Urban Health. 2007;84(Suppl 1):65–74.CrossRef
12.
13.
Alemu A, Shiferaw Y, Addis Z, Mathewos B, Birhan W. Effect of malaria on HIV/AIDS transmission and progression. Parasit Vectors. 2013;6(18):1–8.
14.
Bastos FI, Barcellos C, Lowndes SM, Friedman SR. Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health. Addiction. 1999;94(8):1165–74.CrossRef
15.
Chirenda J, Siziya S, Tshimanga M. Association of HIV infection with the development of severe and complicated malaria cases at a rural hospital in Zimbabwe. Cent Afr J Med. 2000;46:5–9.PubMed
16.
Lagarde E, Congo Z, Meda N, Baya B, Yaro S, Sangli G. Epidemiology of HIV infection in urban Burkina Faso. Int J STD AIDS. 2004;15:395–402.CrossRef
17.
Herrero MD, Rivas P, Rallon N, Ramirez-Olivencia G, Puente S. HIV and malaria. AIDS Rev. 2007;9:88–98.PubMed
18.
Alemu K, Worku A, Berhane Y. Malaria infection has spatial, temporal, and spatiotemporal heterogeneity in unstable malaria transmission areas in Northwest Ethiopia. PLoS One. 2013;8(11):e79966.CrossRef
19.
Cuadros DF, Awad SF, Abu-Raddad LJ. Mapping HIV clustering: a strategy for identifying populations at high risk of HIV infection in sub-Saharan Africa. Int J Health Geogr. 2013;12(28):1–9.
20.
Cuadros DF, Abu-Raddad LJ. Spatial variability in HIV prevalence declines in several countries in sub-Saharan Africa. Health &Place. 2014;28:45–9.CrossRef
21.
Clements ACA, Marie-Alice D, Ndayishimiye O, Brooker S, Fenwick A. Spatial co-distribution of neglected tropical diseases in the east African Great Lakes region: revisiting the justification for integrated control. Trop Med Int Health. 2010;15(2):198–207.CrossRef
22.
Pullan RL, Sturrock HJW, Magalhaes RJS, Clements ACA, Brooker SJ. Spatial parasite ecology and epidemiology: a review of methods and applications. Parasitology. 2012;139(14):1870–87.CrossRef
23.
World Health Organization (WHO). Technical Consultation on Malaria and HIV and their Interactions and Public Health Policy Implications. Geneva: WHO; 2004.
24.
Wumba RD, Zanga J, Aloni MN, Mbanzulu K, Kahindo A, Mandina MN, Ekila MB, Mouri O, Kendjo E. Interactions between malaria and HIV infections in pregnant women: a first report of the magnitude, clinical and laboratory features, and predictive factors in Kinshasa the Democratic Republic of Congo. Malaria Journal. 2015;14(82):1–11.
25.
World Health Organisation (WHO). Report of the first meeting of WHO Strategic and Technical Advisory Group on Neglected Tropical Diseases. Geneva: WHO; 2007.
26.
Gwitira I, Murwira A, Zengeya FM, Shekede MD. Application of GIS to predict malaria hotspots based on Anopheles arabiensis habitat suitability in southern Africa. Int J Appl Earth Obs Geoinformation. 2018;64:12–21.CrossRef
27.
Wiwatnitkit V. Co-infection between TB and malaria: a consideration on interaction of molecules and pathogenesis. Journal of vector-borne diseases. 2006;43:195–7.
28.
Kulldorff M, Nagarwalla N. Spatial disease clusters: detection and inference. Stat Med. 1995;14(8):799–810.CrossRef
29.
Adjuik M, Smith T, Clark S, Todd J, Gamb A, Kinfu Y, Kahn K, Mola M. Cause specific mortality rates in sub-Saharan Africa and Bangladesh. Bulletin of World Health Organisation. 2006;84(3):1–17.
30.
Cuadros DF, Branscum AJ, Crowley PH. HIV-malaria co-infection: effects of malaria on the prevalence of HIV in east sub-Saharan Africa. Int J Epidemiol. 2011;40(4):931–9.CrossRef
31.
Marshall B. The fishes of Zimbabwe and their biology. Grahamstown: The South African Institute for Aquatic Biodiversity: Monograph 3; 2010. p. 1–286.
32.
Torrance JD. Climate handbook of Zimbabwe, vol. 222. Harare: Department of Meteorological Services; 1981.
33.
Ministry of Health and Child Care (MOHCC). Zimbabwe National Malaria Control Programme 2014–2015. Harare: MOHCC; 2014.
34.
Midzi N, Kavhu B, Manangazira P, Phiri I, Mutambu SL, Tshuma C, Chimbari MJ, Munyati S, Midzi SM, Charimari L, Ncube A, Mutsaka-Makuvaza MJ, Soko W, Madzima E, Hlerema G, Mbedzi J, Mhlanga G, Masocha M. Inclusion of edaphic predictors for enhancement of models to determine distribution of soil-transmitted helminths: the case of Zimbabwe. Parasites & Vectors. 2018;11(47):1–13.
35.
Zimbabwe National Statistics Agency (ZIMSTAT). Zimbabwe Population Census 2012. Harare: ZIMSTAT; 2012.
36.
Zimbabwe National Statistics Agency (ZIMSTAT). Zimbabwe Population Projections Thematic Report. Harare: ZIMSTAT; 2015.
37.
Kulldorff M. A spatial scan statistic. Communications in Statistics -Theory and Methods. 1997;26:1481–96.CrossRef
38.
Kulldorff M, Feuer EJ, Miller BA, Freedman LS. Breast cancer clusters in the Northeast United States: a geographic analysis. Am J Epidemiology. 1997;146(2):161–70.CrossRef
39.
Kulldorff M, Heffernan R, Hartman J, Assuncao R, Mostashari F. A space–time permutation scan statistic for disease outbreak detection. PLoS Med. 2005;2(3):216–24.CrossRef
40.
Cheung YTD, Spittal MJ, Williamson MK, Tung SJ, Pirkis J. Application of scan statistics to detect suicide clusters in Australia. PLoS One. 2013;8(1):e54168.CrossRef
41.
Coleman M, Coleman M, Mabuza AM, Kok G, Coetzee M, Durrheim DN. Using the SaTScan method to detect local malaria clusters for guiding malaria control programmes. Malar J. 2009;8:68.CrossRef
42.
Aamodt G, Samuelsen SO. Skrondal a. a simulation study of three methods for detecting disease clusters. Int J Health Geogr. 2006;5(15).CrossRef
43.
Wand H, Ramjee G. Targeting the hotspots: investigating spatial and demographic variations in HIV infection in small communities in South Africa. J Int AIDS Soc. 2010;13(1):41.CrossRef
44.
Chen J, Roth RE, Naito AT, Lengerich EJ, MacEachren AM. Geovisual analytics to enhance spatial scan statistic interpretation: an analysis of US cervical cancer mortality. Int J Health Geogr. 2008;7(1):57.CrossRef
45.
Zhang W, Wang L, Fang L, Ma J, Xu Y, Jiang J, Hui F, Wang J, Liang S, Yang H. Spatial analysis of malaria in Anhui province, China. Malar J. 2008;7(1):206.CrossRef
46.
Kulldorff M. Commentary: geographical distribution of sporadic Creutzfeldt-Jakob disease in France. Int J Epidemiol. 2002;31(2):495–6.CrossRef
47.
48.
Liu Y, Wang X, Liu Y, Sun D, Ding S, Zhang B, Du Z, Xue F. Detecting spatial-temporal clusters of HFMD from 2007 to 2011 in Shandong Province, China. PLoS One. 2013;8(5):e63447.CrossRef
49.
Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, Takken W, Ghani A, Drakeley C, Gosling R. Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med. 2012;9:e1001165.CrossRef
50.
ESRI. ArcGIS Desktop: Release 10.3. Redlands CA: Environmental Systems Research Institute; 2011.
51.
Vitoria M, Granich R, Gilks CF, Gunneberg C, Hosseini M, Were W, Raviglione M, De Cock KM. The global fight against HIV/AIDS, tuberculosis, and malaria current status and future perspectives. Am J Clin Pathol. 2009;131(6):844–8.CrossRef
52.
Hotez PJ, Molyneux DH, Fenwick A. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis and malaria. PLoS Med. 2006;3:e102.CrossRef
53.
Hotez PJ, Molyneux DH, Fenwick A. Control of neglected tropical diseases. N Engl J Med. 2007;357:1018–27.CrossRef
54.
Ngarakana-Gwasira ET, Bhunu CP, Masocha M, Mashonjowa E. Assessing the Role of Climate Change in Malaria Transmission in Africa. Malaria Research and Treatment. 2016;2016:1–7.CrossRef
55.
Idemyor V. Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two titans. HIV Clin Trials. 2007;8(4):246–53.CrossRef
56.
Korenromp EL, Williams BG, de Vlas SJ, Gouws E, Gilks CF, Ghys PD, Nahlen BL. Malaria attributable to the HIV-1 epidemic sub-Saharan Africa. Emerg Infect Dis. 2005;11(9):1410–9.CrossRef
57.
Cuadros DF, Branscum, AJ, Garcı´a-Ramos G. No Evidence of Association between HIV-1 and Malaria in Populations with Low HIV-1 Prevalence. PLoS ONE. 2011;6(8):1–6.CrossRef
58.
Ruperez M. Mortality, morbidity, and developmental outcomes in infants born to women who received either Mefloquine or Sulfadoxine-Pyrimethamine as intermittent preventive treatment of malaria in pregnancy: a cohort study. PLoS Med. 2016;13(2):e1001964.CrossRef
59.
Rattanapunya S, Kuesap J, Chaijaroenkul W, Na-bangchang K. Prevalence of malaria and HIV coinfection and influence of HIV infection on malaria disease severity in population residing in malaria endemic area along the Thai–Myanmar border. Acta Tropica. 2015;145:55–60.CrossRef
60.
Zimbabwe National Statistics Agency (ZIMSTAT). Zimbabwe Poverty Atlas. Harare, ZIMSTAT; 2015.
61.
Kangoye DT, Noor A, Midega J, Mwongeli J, Mkabili D, Mogeni P, Kerubo C, Akoo P, Mwangangi J, Drakeley C, Marsh K, Bejon P, Njuguna P. Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan coast. Malar J. 2016;15(213):1–13.
62.
Kahn JG, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, Mermin J, Shariff S. Integrated HIV testing, malaria, and Diarrhoea prevention campaign in Kenya: modeled health impact and cost-effectiveness. PLoS One. 2012;7(2):e31316.CrossRef
63.
Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL. Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? Glob Health Action. 2015;8:27695.CrossRef
64.
Adeola AM, Botai OJ, Olwoch JM, Rautenbach CJ, Adisa OM, Taiwo OJ, Kalumba AM. Environmental factors and population at risk of malaria in Nkomazi municipality, South Africa. Trop Med Int Health. 2016;21(5):675–86.CrossRef
65.
66.
Rulisa S, Kateera F, Bizimana JP, Agaba S, Dukuzumuremyi J, Baas L. Malaria prevalence, spatial clustering and risk factors in a low endemic area of eastern Rwanda: a cross sectional study. PLoS One. 2013;8:e69443.CrossRef
67.
Sande S, Zimba M, Chinwada P, Masendu HT, Mberikunshe J. Makuwaza a. a review of new challenges and prospects for malaria elimination in Mutare and Mutasa districts, Zimbabwe. Malar J. 2016;15(1):360.CrossRef
68.
Snow R, Guerra C, Noor A, Myint H, Hay S. The global distribution of clinical episodes of plasmodium falciparum malaria. Nature. 2005;434:214–7.CrossRef
Metadata
Title
Spatial overlaps in the distribution of HIV/AIDS and malaria in Zimbabwe
Authors
Isaiah Gwitira
Amon Murwira
Joseph Mberikunashe
Mhosisi Masocha
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3513-y

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue

Research article

Molecular epidemiology of Neisseria gonorrhoeae strains circulating in Indonesia using multi-locus variable number tandem repeat analysis (MLVA) and Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) techniques

Research article

Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students

Research article

Comparison of qPCR and culture methods for group B Streptococcus colonization detection in pregnant women: evaluation of a new qPCR assay

Case report

Cryptococcal fungemia and probable histoplasmosis in a patient infected with HIV. Case report

Research article

Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults

Research article

Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits